Latest Articles

Publication Date
Mechanism of action of HuPoSan on EMs rats as revealed by multi-omics combined with network pharmacology - ScienceDirect.com

Mechanism of action of HuPoSan on EMs rats as revealed by multi-omics combined with network pharmacology ScienceDirect.com

Published: Oct. 27, 2025, 6 a.m.
Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors - The Manila Times

Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors The Manila Times

Published: Oct. 24, 2025, 3:57 p.m.
KEYTRUDA + LENVIMA shows durable 5-year survival benefit in advanced endometrial cancer - Indian Pharma Post

KEYTRUDA + LENVIMA shows durable 5-year survival benefit in advanced endometrial cancer Indian Pharma Post

Published: Oct. 22, 2025, 5:03 p.m.
Cedars-Sinai Expert Discusses Endometriosis and Fibroids - Cedars-Sinai

Cedars-Sinai Expert Discusses Endometriosis and Fibroids Cedars-Sinai

Published: Oct. 22, 2025, 4 p.m.
‘It’s not just cramps’: Women forced to seek endometriosis treatment privately amid long NHS waiting times - Suffolk News

‘It’s not just cramps’: Women forced to seek endometriosis treatment privately amid long NHS waiting times Suffolk News

Published: Oct. 22, 2025, 4 a.m.
KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer - Pharmacy Times

KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer Pharmacy Times

Published: Oct. 21, 2025, 3:34 a.m.
Symptoms Of Endometrosis Experienced By Barbara Palvin, A Disease Often Ignored By Women - VOI.ID

Symptoms Of Endometrosis Experienced By Barbara Palvin, A Disease Often Ignored By Women VOI.ID

Published: Oct. 20, 2025, 9:35 p.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - BioSpace

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer BioSpace

Published: Oct. 20, 2025, 4:42 a.m.
Dominique Dagenais Cedars Run for ovarian cancer marks a decade and honours its late founder in Montreal - CityNews Montreal

Dominique Dagenais Cedars Run for ovarian cancer marks a decade and honours its late founder in Montreal CityNews Montreal

Published: Oct. 19, 2025, 3:21 p.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - Lelezard

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer Lelezard

Published: Oct. 18, 2025, 12:47 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!